Worth Venture Partners, LLC Vascular Biogenics Ltd. Call Options Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2018

Aug 13, 2018
SELL
$2.05 - $3.0 $53,504 - $78,300
-26,100 Closed
0 $0
Q1 2018

May 25, 2018
SELL
$2.27 - $8.5 $5.87 Million - $22 Million
-2,583,900 Reduced 99.0%
26,100 $2,000
Q1 2018

May 11, 2018
BUY
$2.27 - $8.5 $5.92 Million - $22.2 Million
2,610,000 New
2,610,000 $2,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email